KAREN RHODES: Open Payments
NPI 1346587540 · MINDEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,155 in 121 payments from 28 companies in 2025. Trend: 2023 $2,004 · 2024 $1,766 · 2025 $2,155
Food & beverage: $2,155
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $312 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $146 |
| GlaxoSmithKline, LLC. | 7 | $139 |
| Alkermes, Inc. | 10 | $135 |
| Astellas Pharma US Inc | 7 | $118 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| Ardelyx, Inc. | 5 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| PFIZER INC. | 5 | $87 |
| Amgen Inc. | 5 | $87 |
Products named: VRAYLAR, Kerendia, TRELEGY ELLIPTA, Veozah, FANAPT, REXULTI, ARISTADA, IBSRELA.
Industry payments across LA — which companies pay providers there.
